Maravai LifeSciences (MRVI) News Today $2.35 -0.02 (-0.84%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$2.36 +0.00 (+0.21%) As of 03/27/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period MRVI LAWSUIT ALERT: Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMarch 28 at 5:45 AM | prnewswire.comContact Levi & Korsinsky by May 5, 2025 Deadline to Join Class Action Against Maravai LifeSciences Holdings, Inc. (MRVI)March 27 at 1:03 PM | globenewswire.comROSEN, A RANKED AND LEADING FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVIMarch 27 at 12:48 PM | globenewswire.comMaravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMarch 27 at 12:00 PM | prnewswire.comMaravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMarch 27 at 12:00 PM | prnewswire.comClass Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) Seeking Recovery for Investors - Contact The Gross Law FirmMarch 27 at 5:45 AM | prnewswire.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Recommendation of "Hold" from AnalystsMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) has been assigned an average recommendation of "Hold" from the twelve research firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, seven have given a hold rating and four haMarch 27 at 2:37 AM | marketbeat.comMRVI INVESTOR DEADLINE: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitMarch 26 at 6:44 PM | markets.businessinsider.comFaruqi & Faruqi Reminds Maravai Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVIMarch 26 at 4:21 PM | globenewswire.comMRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMarch 26 at 4:00 PM | globenewswire.comMRVI Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Contact the Firm About Securities Fraud Class Action LawsuitMarch 26 at 3:04 PM | prnewswire.comMaravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens BermanMarch 26 at 2:24 PM | globenewswire.comMaravai LifeSciences (NASDAQ:MRVI) Trading Up 4.7% - Time to Buy?Maravai LifeSciences (NASDAQ:MRVI) Shares Up 4.7% - Time to Buy?March 26 at 1:28 PM | marketbeat.comMorgan Stanley Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock PriceMorgan Stanley lowered their price objective on Maravai LifeSciences from $7.00 to $5.00 and set an "equal weight" rating on the stock in a research report on Tuesday.March 26 at 10:51 AM | marketbeat.comMRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmMarch 26 at 9:46 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVIMarch 26 at 8:00 AM | globenewswire.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Purchased by Pier Capital LLCPier Capital LLC raised its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 137.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,127,773 shares of theMarch 26 at 6:38 AM | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF), Outset Medical (OM) and Maravai Lifesciences Holdings (MRVI)March 26 at 5:33 AM | markets.businessinsider.comMorgan Stanley Cuts Maravai LifeSciences (NASDAQ:MRVI) Price Target to $5.00March 26 at 2:52 AM | americanbankingnews.com4MRVI : Breaking Down Maravai LifeSciences: 4 Analysts Share Their ViewsMarch 25 at 7:31 PM | benzinga.comIs Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management?March 25 at 7:31 PM | msn.comLevi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVIMarch 25 at 5:52 PM | prnewswire.comMRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud LawsuitMarch 25 at 5:13 PM | prnewswire.comMaravai LifeSciences (NASDAQ:MRVI) Trading Down 2.9% Following Analyst DowngradeMaravai LifeSciences (NASDAQ:MRVI) Shares Down 2.9% After Analyst DowngradeMarch 25 at 2:14 PM | marketbeat.comWolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc.March 25 at 10:21 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVIMarch 25 at 10:00 AM | prnewswire.comMaravai LifeSciences (NASDAQ:MRVI) Shares Down 2.9% on Analyst DowngradeMarch 25 at 1:18 AM | americanbankingnews.comROSEN, A TOP RANKED LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVIMarch 24, 2025 | globenewswire.comMaravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens BermanMarch 24, 2025 | globenewswire.comMaravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights – MRVIMarch 24, 2025 | globenewswire.comONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesMarch 24, 2025 | tmcnet.comLost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmMarch 24, 2025 | prnewswire.comMRVI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitMarch 24, 2025 | globenewswire.comWells Fargo Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)March 24, 2025 | markets.businessinsider.comUBS Group Cuts Maravai LifeSciences (NASDAQ:MRVI) Price Target to $2.50March 24, 2025 | americanbankingnews.comClass Action Reminder for MRVI Investors: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors of Securities Fraud Class Action LawsuitMarch 23, 2025 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesMarch 23, 2025 | globenewswire.comMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Down Following Analyst DowngradeMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Down Following Analyst DowngradeMarch 22, 2025 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Given New $2.50 Price Target at UBS GroupUBS Group cut their target price on shares of Maravai LifeSciences from $8.00 to $2.50 and set a "neutral" rating on the stock in a research report on Friday.March 22, 2025 | marketbeat.comMaravai LifeSciences (MRVI) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | msn.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVIMarch 21, 2025 | globenewswire.comShareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights – MRVIMarch 21, 2025 | globenewswire.comMaravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens BermanMarch 21, 2025 | globenewswire.comMRVI Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders of Deadline in Securities Fraud Class Action LawsuitMarch 21, 2025 | prnewswire.comLowey Dannenberg Notifies Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmMarch 21, 2025 | globenewswire.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Maravai LifeSciences Holdings, Inc.(MRVI) ShareholdersMarch 21, 2025 | prnewswire.comMaravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI)March 21, 2025 | americanbankingnews.comMaravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call TranscriptMarch 20, 2025 | seekingalpha.comMaravai LifeSciences Holdings, Inc. 2024 Q4 - Results - Earnings Call PresentationMarch 20, 2025 | seekingalpha.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Short Interest Down 14.4% in FebruaryMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 8,820,000 shares, a drop of 14.4% from the February 13th total of 10,300,000 shares. Approximately 3.5% of the company's shares are short sold. Based on an average daily volume of 2,640,000 shares, the short-interest ratio is currently 3.3 days.March 20, 2025 | marketbeat.com Remove Ads Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address MRVI Media Mentions By Week MRVI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRVI News Sentiment▼0.050.78▲Average Medical News Sentiment MRVI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRVI Articles This Week▼498▲MRVI Articles Average Week Remove Ads Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EWTX News CNTA News KYMR News CGON News DNLI News BLTE News ARWR News ARQT News TARS News HRMY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRVI) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maravai LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
